rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Nexalin Technology, Inc.

NXL · Nasdaq

Health CareMedical DevicesNot moving yet

NXL stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 77.1% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
21 (-1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$13KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders21-1 on the quarter
New · exited5 · 6
Reported value$282K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
PEAK6 LLCreduced · filed 13 Aug 2026240,210$79K-144,250−37.5%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026139,583$46K-107,454−43.5%
VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026126,536$42K00.0%
CITADEL ADVISORS LLCnew · filed 14 Aug 202675,398$25K+75,398
JANE STREET GROUP, LLCadded · filed 14 Aug 202665,497$22K+54,987+523.2%
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 202651,386$17K00.0%
STATE STREET CORPunchanged · filed 7 Aug 202632,300$11K00.0%
UBS Group AGadded · filed 13 Aug 202626,825$8,852+4,636+20.9%
NORTHERN TRUST CORPunchanged · filed 13 Aug 202624,100$7,95300.0%
Kovack Advisors, Inc.reduced · filed 29 Jul 202622,325$8,039-1,000−4.3%
31 Mar 2023 – 30 Jun 2026
41321Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Alan Kazden Company insiderDirector · last 19 Dec 20252 · 0
Ben Hu Company insiderDirector · last 19 Dec 20250 · 0
Carolyn Hamby Shelton Company insiderSr. VP - Quality - Regulatory · last 19 Dec 20252 · 0
David Owens Company insiderChief Medical Officer · last 19 Dec 202512 · 0
Fleet Justin Van Company insiderCFO · last 19 Dec 20250 · 0
Mark White Company insiderCEO · last 19 Dec 20253 · 0
Leonard Osser Company insider10% owner · last 29 Sep 20252 · 0
Marilyn Elson Company insider10% owner · last 17 Jul 20250 · 0
Leslie Bernhard Company insiderDirector · last 30 Sep 20240 · 0
Rick Morad Company insiderDirector · last 16 Sep 20222 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%
PLSE Pulse BiosciencesLeading+33%
INFU InfuSystems HoldingsLeading+27%
SMTI Sanara MedTechLeading+26%
ITGR Integer HoldingsLeading+23%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202579.7%
Research spendFY 2025 · to 31 Dec 2025359%
Share count trendFY 2025 · to 23 Mar 20267.3%
Cash and equivalentsFY 2025 · to 31 Dec 2025$655K

Analyst forecasts

No analyst forecasts yet.